Long term efficacy and tolerability of indiplon-ir in the treatment of chronic insomnia: Results of a double-blind, placebo-controlled 3-month study

被引：0
|
作者：
Scharf, MB
Black, J
Hull, S
Mahowald, M
Moscovitch, A
Farber, R
Jochelson, P
机构：
[1] Tri State Sleep Disorders Ctr, Cincinnati, OH USA
[2] Sleep Clin San Francisco, San Francisco, CA USA
[3] Vince & Associates Clin Res, Overland Pk, KS USA
[4] Minnesota Reg Sleep Disorders Ctr, Minneapolis, MN USA
[5] CSI Res Ctr, Calgary, AB, Canada
[6] Neurocrine Biosci, San Diego, CA USA
来源：
SLEEP | 2005年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
682
引用
收藏
页码：A229 / A229
页数：1
相关论文
共 50 条
  • [21] A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain
    Daniels, Stephen
    Casson, Ed
    Stegmann, Jens-Ulrich
    Oh, Charles
    Okamoto, Akiko
    Rauschkolb, Christine
    Upmalis, David
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (06) : 1551 - 1561
  • [22] TREATMENT OF INSOMNIA WITH TEMAZEPAM - DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION
    CUANANG, JR
    LIMOS, L
    [J]. CLINICAL THERAPEUTICS, 1982, 4 (05) : 402 - 412
  • [23] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 3-MONTH TREATMENT WITH LYMECYCLINE IN REACTIVE ARTHRITIS, WITH SPECIAL REFERENCE TO CHLAMYDIA ARTHRITIS
    LAUHIO, A
    LEIRISALOREPO, M
    LAHDEVIRTA, J
    SAIKKU, P
    REPO, H
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (01): : 6 - 14
  • [24] Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 4-week, double-blind, placebo-controlled outpatient study
    Hedner, J.
    Loft, H.
    Hajak, G.
    Lundahl, J.
    Hedegaard, K.
    Knoth, Sorensen H.
    Torstenson, R.
    [J]. SLEEP, 2007, 30 : A249 - A249
  • [25] Efficacy and safety of zolpidem administered -: 'As needed' in primary insomnia results of a double-blind, placebo-controlled study
    Allain, H
    Arbus, L
    Schück, S
    [J]. CLINICAL DRUG INVESTIGATION, 2001, 21 (06) : 391 - 400
  • [26] Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study
    Uchimura, Naohisa
    Ogawa, Atsushi
    Hamamura, Misako
    Hashimoto, Takamasa
    Nagata, Hiroshi
    Uchiyama, Makoto
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (02) : 215 - 224
  • [27] Doxepin in the treatment of primary insomnia:: A placebo-controlled, double-blind, polysomnographic study
    Hajak, G
    Rodenbeck, A
    Voderholzer, U
    Riemann, D
    Cohrs, S
    Hohagen, F
    Berger, M
    Rüther, E
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (06) : 453 - 463
  • [28] A phase 3 placebo-controlled study of galcanezumab in patients with treatment-resistant migraine: Results from the 3-month double-blind treatment phase of the conquer study
    Mulleners, W.
    Kim, B.
    Lainez, M. J.
    Lanteri-Minet, M.
    Aurora, S. K.
    Nichols, R. M.
    Wang, S.
    Tockhorn-Heidenreich, A.
    Detke, H.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [29] Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study
    Montes, LGA
    Uribe, MPO
    Sotres, JC
    Martin, GH
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2003, 28 (03): : 191 - 196
  • [30] Zolpidem "as needed" for the treatment of primary insomnia: A double-blind, placebo-controlled study
    Walsh, JK
    [J]. SLEEP MEDICINE REVIEWS, 2002, 6 : S7 - S11
12345